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New bandwidth selection criterion for Kernel PCA: Approach to
dimensionality reduction and classification problems
Abstract
Background: DNA microarrays are potentially powerful technology for improving diagnostic classification,
treatment selection, and prognostic assessment. The use of this technology to predict cancer outcome has a
history of almost a decade. Disease class predictors can be designed for known disease cases and provide
diagnostic confirmation or clarify abnormal cases. The main input to this class predictors are high dimensional
data with many variables and few observations. Dimensionality reduction of these features set significantly
speeds up the prediction task. Feature selection and feature transformation methods are well known
preprocessing steps in the field of bioinformatics. Several prediction tools are available based on these
techniques. Results: Studies show that a well tuned Kernel PCA (KPCA) is an efficient preprocessing step for
dimensionality reduction, but the available bandwidth selection method for KPCA was computationally
expensive. In this paper, we propose a new data-driven bandwidth selection criterion for KPCA, which is
related to least squares cross-validation for kernel density estimation. We propose a new prediction model
with a well tuned KPCA and Least Squares Support Vector Machine (LS-SVM). We estimate the accuracy of
the newly proposed model based on 9 case studies. Then, we compare its performances (in terms of test set
Area Under the ROC Curve (AUC) and computational time) with other well known techniques such as
whole data set + LS-SVM, PCA + LS-SVM, t-test + LS-SVM, Prediction Analysis of Microarrays (PAM) and
Least Absolute Shrinkage and Selection Operator (Lasso). Finally, we assess the performance of the proposed
strategy with an existing KPCA parameter tuning algorithm by means of two additional case studies.
Conclusion: We propose, evaluate, and compare several mathematical/statistical techniques, which apply
feature transformation/selection for subsequent classification, and consider its application in medical
diagnostics. Both feature selection and feature transformation perform well on classification tasks. Due to the
dynamic selection property of feature selection, it is hard to define significant features for the classifier, which
predicts classes of future samples. Moreover, the proposed strategy enjoys a distinctive advantage with its
relatively lesser time complexity.
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Abstract
Background: DNAmicroarrays are potentially powerful technology for improving diagnostic classification, treatment
selection, and prognostic assessment. The use of this technology to predict cancer outcome has a history of almost a
decade. Disease class predictors can be designed for known disease cases and provide diagnostic confirmation or
clarify abnormal cases. The main input to this class predictors are high dimensional data with many variables and few
observations. Dimensionality reduction of these features set significantly speeds up the prediction task. Feature
selection and feature transformation methods are well known preprocessing steps in the field of bioinformatics.
Several prediction tools are available based on these techniques.
Results: Studies show that a well tuned Kernel PCA (KPCA) is an efficient preprocessing step for dimensionality
reduction, but the available bandwidth selection method for KPCA was computationally expensive. In this paper, we
propose a new data-driven bandwidth selection criterion for KPCA, which is related to least squares cross-validation
for kernel density estimation. We propose a new prediction model with a well tuned KPCA and Least Squares Support
Vector Machine (LS-SVM). We estimate the accuracy of the newly proposed model based on 9 case studies. Then, we
compare its performances (in terms of test set Area Under the ROC Curve (AUC) and computational time) with other
well known techniques such as whole data set + LS-SVM, PCA + LS-SVM, t-test + LS-SVM, Prediction Analysis of
Microarrays (PAM) and Least Absolute Shrinkage and Selection Operator (Lasso). Finally, we assess the performance of
the proposed strategy with an existing KPCA parameter tuning algorithm by means of two additional case studies.
Conclusion: We propose, evaluate, and compare several mathematical/statistical techniques, which apply feature
transformation/selection for subsequent classification, and consider its application in medical diagnostics. Both
feature selection and feature transformation perform well on classification tasks. Due to the dynamic selection
property of feature selection, it is hard to define significant features for the classifier, which predicts classes of future
samples. Moreover, the proposed strategy enjoys a distinctive advantage with its relatively lesser time complexity.
Background
Biomarker discovery and prognosis prediction are essen-
tial for improved personalized cancer treatment. Microar-
ray technology is a significant tool for gene expression
analysis and cancer diagnosis. Typically, microarray data
sets are used for class discovery [1,2] and prediction [3,4].
The high dimensionality of the input feature space in com-
parison with the relatively small number of subjects is a
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widespread concern; hence some form of dimensionality
reduction is often applied. Feature selection and feature
transformation are two commonly used dimensionality
reduction techniques. The key difference between feature
selection and feature transformation is that, in the former
only a subset of original features is selected while the latter
is based on generation of new features.
In this genomic era, several classification and dimen-
sionality reduction methods are available for analyz-
ing and classifying microarray data. Prediction Analysis
of Microarray (PAM) [5] is a statistical technique for
class prediction from gene expression data using Nearest
Shrunken Centroid (NSC). PAM identifies subsets of
© 2014 Thomas et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited.
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genes that best characterize each class. LS-SVM is a
promising method for classification, because of its solid
mathematical foundations which convey several salient
properties that other methods hardly provide. A com-
monly used technique for feature selection, t-test, assumes
that the feature values from two different classes follow
normal distributions. Several studies, especially microar-
ray analysis, have used t-test and LS-SVM together to
improve the prediction performance by selecting key fea-
tures [6,7]. The Least Absolute Shrinkage and Selection
Operator (Lasso) [8] is often used for gene selection
and parameter estimation in high-dimensional microar-
ray data [9]. The Lasso shrinks some of the coefficients to
zero, and extend of shrinkage is determined by the tuning
parameter, often obtained from cross validation.
Inductive learning systems were successfully applied
in a number of medical domains, e.g. in localization of
primary tumors, prognostic of recurring breast cancer,
diagnosis of thyroid diseases, and rheumatology [10]. An
induction algorithm is used to learn a classifier, which
maps the space of feature values into the set of class values.
This classifier is later used to classify new instances, with
the unknown classifications (class labels). Researchers and
practitioners realize that the effective use of these induc-
tive learning systems requires data preprocessing, before
a learning algorithm could be applied [11]. Due to the
instability of feature selection techniques, it might be
difficult or even impossible to remove irrelevant and/or
redundant features from a data set. Feature transforma-
tion techniques, such as KPCA, discover a new feature
space having fewer dimensions through a functional map-
ping, while keeping as much information, as possible in
the data set.
KPCA, which is a generalization of PCA, a nonlin-
ear dimensionality reduction technique that has proven
to be a powerful pre-processing step for classification
algorithms. It has been studied intensively in the last
several years in the field of machine learning and has
claimed success in many applications [12]. An algorithm
for classification using KPCA was developed by Liu et al.
[13]. KPCA was proposed by Schölkopf and Smola [14],
by mapping features sets to a high-dimensional feature
space (possibly infinite) and applying Mercer’s theorem.
Suykens et al. [15,16] proposed a simple and straightfor-
ward primal-dual support vector machine formulation to
the PCA problem.
To perform KPCA, the user first transforms the input
data x from the original input space F0 into a higher-
dimensional feature space F1 with a nonlinear transform
x → (x) where  is a nonlinear function. Then a ker-
nel matrix K is formed using the inner products of new
feature vectors. Finally, a PCA is performed on the cen-
tralized K, which is an estimate of the covariance matrix
of the new feature vectors in F1. One of the commonly
used kernel function is radial basis function (RBF) kernel:
K(xi, xj) = exp
(
−‖xi−xj‖22h2
)
(RBF kernel with bandwidth
h). Traditionally the optimal parameters (bandwidth and
number of principal components) of RBF kernel function
are selected in a trial and error fashion.
Pochet et al. [17] proposed an optimization algorithm
for KPCA with RBF kernel followed by Fisher Discrimi-
nant Analysis (FDA) to find the parameters of KPCA. In
this case, the parameter selection is coupled with the cor-
responding classifier. This means that the performance of
the final procedure depends on the chosen classifier. Such
a procedure could produce possible inaccurate results in
the case of weak classifiers. In addition, this appears to be
a time consuming procedure, while tuning the parameters
of KPCA.
Most classificationmethods have inherent problemwith
high dimensionality of microarray data and hence require
dimensionality reduction. The ultimate goal of our work is
to design a powerful preprocessing step, decoupled from
the classification method, for large dimensional data sets.
In this paper, initially we explain an SVM approach to
PCA and LS-SVM approach to KPCA. Next, by following
the idea of least squares cross-validation in kernel den-
sity estimation, we propose a new data-driven bandwidth
selection criterion for KPCA. The tuned LS-SVM formu-
lation to KPCA is applied to several data sets and serves as
a dimensionality reduction technique for a final classifica-
tion task. In addition, we compared the proposed strategy
with an existing optimization algorithm for KPCA, as well
as with other preprocessing steps. Finally, for the sake
of comparison, we applied LS-SVM on whole data sets,
PCA+LS-SVM, t-test + LS-SVM, PAM and Lasso. Ran-
domization on all data sets are carried out in order to get
a more reliable idea of the expected performance.
Data sets
In our analysis, we collected 11 publicly available binary
class data sets (diseased vs. normal). The data sets
are: colon cancer data [18,19], breast cancer data [20],
pancreatic cancer premalignant data [21,22], cervical
cancer data [23], acute myeloid leukemia data[24], ovarian
cancer data [21], head & neck squamous cell carcinoma
data [25], early-early stage duchenne muscular dystrophy
(EDMD) data [26], HIV encephalitis data [27], high grade
glioma data [28], and breast cancer data [29]. In breast
cancer data [29] and high grade glioma data, all data sam-
ples have already been assigned to a training set or test
set. The breast cancer data in [29] contains missing values;
those values have been imputed based on the nearest
neighbor method.
An overview of the characteristics of all the data sets can
be found in Table 1. In all the cases, 2/3rd of the data sam-
ples of each class are assigned randomly to the training
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Table 1 Summary of the 11 binary disease data sets
Data set #Samples #Genes
Class 1 Class 2
1: Colon 22 40 2000
2: Breast cancer I 34 99 5970
3: Pancreatic 50 50 15154
4: Cervical 8 24 10692
5: Leukemia 26 38 22283
6: Ovarian 91 162 15154
7: Head & neck squamous
cell carcinoma 22 22 12625
8: Duchenne muscular dystrophy 23 14 22283
9: HIV encephalitis 16 12 12625
10: High grade glioma 29 21 12625
11: Breast cancer II 19 78 24188
and the rest to the test set. These randomizations are the
same for all numerical experiments on all data sets. This
split was performed stratified to ensure that the relative
proportion of outcomes sampled in both training and test
set was similar to the original proportion in the full data
set. In all these cases, the data were standardized to zero
mean and unit variance.
Methods
The methods used to set up the case studies can be subdi-
vided into two categories: dimensionality reduction using
the proposed criterion and subsequent classification.
SVM formulation to linear PCA
Given training set{xi}Ni=1, xi ∈ Rd (d - dimensional data)
and N given data points for which one aims at find-
ing projected variables vTxi with maximal variance. SVM
formulation to PCA problem is given in [30] as follows:
max
v
N∑
i=1
[
0− vTxi
]2
where zero is considered as a single target value. This
interpretation of the problem leads to the following primal
optimization problem
max
v,e
JP(v, e) = γ 12
N∑
i=1
e2i −
1
2v
Tv
such that
ei = vTxi, i = 1, . . . ,N .
This formulation states that one considers the difference
between vTxi (the projected data points to the target
space) and the value 0 as error variables. The projected
variables correspond to what one calls the score variables.
These error variables are maximized for the given N data
points while keeping the norm of v small by the regular-
ization term. The value γ is a positive real constant. The
Lagrangian becomes
L(v, e;α) = γ 12
N∑
k=1
e2k −
1
2v
Tv −
N∑
k=1
αk
(
ek − vTxk
)
with conditions for optimality
⎧⎪⎪⎪⎨
⎪⎪⎪⎩
∂L
∂v = 0 → v =
N∑
k=1
αkxk
∂L
∂ek = 0 → αk = γ ek k = 1, . . . ,N
∂L
∂αk
= 0 → ek − vTxk , k = 1, . . . ,N .
By elimination of the variables e, v one obtains the follow-
ing symmetric eigenvalue problem:
⎡
⎢⎣
xT1 x1 . . . xT1 xN
...
...
xTNx1 . . . xTNxN
⎤
⎥⎦
⎡
⎢⎣
α1
...
αN
⎤
⎥⎦ = λ
⎡
⎢⎣
α1
...
αN
⎤
⎥⎦
The vector of dual variables α = [α1; . . . ;αN ] is an eigen-
vector of the Grammatrix and λ = 1
γ
is the corresponding
eigenvalue. The score variable, znpca(x) of sample x on nth
eigenvector αn becomes
znpca(x) = vTx = Ni=1α(n)i xTi x (1)
LS-SVM approach to KPCA
The PCA analysis problem is interpreted as a one-class
modeling problemwith a target value equal to zero around
which the variance is maximized. This results into a sum
of squared error cost function with regularization. The
score variables are taken as additional error variables.
We now follow the usual SVM methodology of mapping
the d-dimensional data from the input space to a high-
dimensional feature space φ : Rd → Rnh , where nh can be
infinite, and apply Mercer’s theorem [31].
Our objective is the following
max
v
N∑
k=1
[
0 − vT (φ(xk) − μˆφ))
]2
(2)
with μˆφ = (1/N)∑Nk=1 φ(xk) and v is the eigenvector
in the primal space with maximum variance. This for-
mulation states that one considers the difference between
vT (φ(xk) − μˆφ) (the projected data points to the target
space) and the value 0 as error variables. The projected
variables correspond to what is called score variables.
These error variables are maximized for the given N data
points. Next, by adding a regularization termwe also want
Thomas et al. BMC Bioinformatics 2014, 15:137 Page 4 of 12
http://www.biomedcentral.com/1471-2105/15/137
to keep the norm of v small. The following optimization
problem is formulated now in the primal weight space
max
v,e
JP(v, e) = γ 12
N∑
k=1
e2k −
1
2v
Tv (3)
such that
ek = vT (φ(xk) − μφ), k = 1, . . . ,N .
The Lagrangian yields
L(v, e;α)=γ 12
N∑
k=1
e2k−
1
2 v
Tv−
N∑
k=1
αk
(
ek−vT
(
φ (xk)−μˆφ
))
with conditions for optimality⎧⎪⎪⎪⎨
⎪⎪⎪⎩
∂L
∂v = 0 → v =
N∑
k=1
αk
(
φ (xk) − μˆφ
)
∂L
∂ek = 0 → αk = γ ek k = 1, . . . ,N
∂L
∂αk
= 0 → ek − vT
(
φ (xk) − μˆφ
) = 0, k = 1, . . . ,N .
By elimination of variables e and v, one obtains
1
γ
αk−
N∑
l=1
αl
(
φ (xl)−μˆφ
)T (
φ (xk)−μˆφ
)= 0 k=1,. . .,N .
Defining λ = 1
γ
, one obtains the following dual problem
	cα = λα
where 	c denotes the centered kernel matrix with ijth
entry: 	c,i,j = K(xi, xj) − 1N
∑N
r=1 K(xi, xr) − 1N
∑N
r=1
K(xj, xr) + 1N2
∑N
r=1
∑N
s=1 K(xr , xs).
Data-driven bandwidth selection for KPCA
Model selection is a prominent issue in all learning tasks,
especially in KPCA. Since KPCA is an unsupervised
technique, formulating a data-driven bandwidth selection
criterion is not trivial. Until now, no such data-driven cri-
terionwas available to tune the bandwidth (h) and number
of components (k) for KPCA. Typically these parameters
are selected by trial and error. Analogue to least squares
cross validation [32,33] in kernel density estimation, we
propose a new data driven selection criterion for KPCA.
Let
zn(x) = Ni=1α(n)i K(xi, x)
where K(xi, xj) = exp
(
−‖xi−xj‖22h2
)
(RBF kernel with band-
width h) and set the target equal to 0 and denote by zn(x)
the score variable of sample x on nth eigenvector α(n).
Here, the score variables are expressed in terms of ker-
nel expressions in which every training point contributes.
These expansions are typically dense (nonsparse). In
Equation 3, the KPCA uses L2 lose function. Here we have
chosen the L1 loss function to induce sparsness in KPCA.
By extending the formulation in Equation 3 to L1 loss
function, the following problem is formulated for kernel
PCA [34].
max
v,e
JP(v, e) = γ 12
N∑
k=1
L1(ek) − 12v
Tv
such that
ek = vT (φ(xk) − μφ), k = 1, . . . ,N .
We propose the following tuning criterion for the band-
width h which maximizes the L1 loss function of KPCA:
J(h) = argmax
h∈R+0
E
∫
|zn(x)|dx, (4)
where E denotes the expectation operator. Maximizing
Eq. 4 would lead to overfitting since we used all the
training data in the criterion. Instead, we workwith Leave-
One-Out cross validation (LOOCV) estimation of zn(x)
to obtain the optimum bandwidth h of KPCA, which
gives projected variables with maximal variance. A finite
approximation to Eq. 4 is given by
J(h) = argmax
h∈R+0
1
N
N∑
j=1
∫
|z(−j)n (x)|dx (5)
where N is the number of samples and z(−j)n denotes the
score variable with the jth observation is left out. In case
the leave-one-out approach is computationally expensive,
one could replace it with a leave v group out strategy
(v- fold cross-validation). Integration can be performed
by means of any numerical technique. In our case, we
have used trapezoidal rule. The final model with optimum
bandwidth is constructed as follows:
	c,hˆmaxα = λα,
where hˆmax = maxh∈R+0
1
N
∑N
j=1
∫ |z(−j)n (x)|dx. Figure 1
shows the bandwidth selection for cervical and colon can-
cer data sets for fixed number of components. To also
retain the optimum number of components of KPCA, we
modify Eq. 5 as follows:
J(h, k) = argmax
h∈R+0 ,k∈N0
1
N
k∑
n=1
N∑
j=1
∫
|z(−j)n (x)|dx (6)
where k = 1, . . . ,N . Figure 2 illustrate the proposed
model. Figure 3 shows the surface plot of Eq. 6 for various
values of h and k.
Thus, the proposed data-driven model can obtain the
optimal bandwidth for KPCA, while retaining minimum
number of eigenvectors which capture the majority of the
variance of the data. Figure 4 shows a slice of the surface
plots. The values of the proposed criterion were re-scaled
to be maximum 1. The parameters that maximize Eq. 6
are h = 70.71 and k = 5 for cervical cancer data and h =
43.59 and k = 15 for colon cancer data.
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Figure 1 Bandwidth selection of KPCA for a fixed number of components. Retaining (a) 5 components for cervical cancer data set (b) 15
components for colon cancer data set.
Classificationmodels
The constrained optimization problem for an LS-SVM
[16,35] for classification has the following form:
min
w,b,e
(1
2w
Tw + γ 12
N
k=1e2k
)
subject to:
yk
[
wTφ(xk) + b
]
= 1 − ek , k = 1, . . . ,N
where φ(.):Rd → Rdh is a nonlinear function which maps
the d-dimensional input vector x from the input space to
the dh-dimensional feature space, possibly infinite. In the
dual space the solution is given by[ 0 yT
y 	 + I
γ
] [
b
β
]
=
[
0
1v
]
with y =[y1, . . . , yN ]T , 1N =[1, . . . , 1]T , e =[e1, . . . , eN ]T ,
β =[β1, . . . , βN ]T and 	i,j = yiyjK(xi, xj) where K(xi, xj)
is the kernel function. The classifier in the dual space takes
the form
y(x) = sign
[ N∑
k=1
βkykK(x, xk) + b
]
(7)
where βk are Lagrange multipliers.
Results
First we considered nine data sets described in Table 1.We
have chosen the RBF kernel K(xi, xj) = exp
(
−||xi−xj||22h2
)
for KPCA. In this section all the steps are implemented
using Matlab R2012b and LS-SVMlab v1.8 toolbox [36].
Next, we compared the performance of the proposed
Figure 2 Data-Driven Bandwidth Selection for KPCA Leave-one-out cross validation (LOOCV) for KPCA.
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Figure 3Model selection for KPCA-optimal bandwidth and number of components. (a) Cervical cancer (b) Colon cancer.
method with classical PCA and an existing tuning algo-
rithm for RBF-KPCA developed by Pochet et al. [17].
Later, with the intention to comprehensively compare
PCA+LS-SVM and KPCA+LS-SVM with other classifica-
tion methods, we applied four widely used classifiers to
the microarray data, being LS-SVM on whole data sets, t-
test + LS-SVM, PAM and Lasso. To fairly compare kernel
functions of the LS-SVM classifier; linear, RBF and poly-
nomial kernel functions are used (in Table 2 referred to
as linear/poly/RBF). The average test accuracies and exe-
cution time for all these methods when applied to the 9
case studies are shown in Table 2 and Table 3 respectively.
Statistical significance test results (two-sided signed rank
test) are given in Table 4 which compares the performance
of KPCA with other classifiers. For all these methods,
training on 2/3rd of the samples and testing on 1/3rd of
the samples was repeated 30 times.
Comparison between the proposed criterion and PCA
For each data set, the proposed methodology is applied.
This methodology consists of two steps. First, Eq. 6 is
maximized in order to obtain an optimal bandwidth h
and corresponding number of components k. Second, the
reduced data set is used to perform a classification task
with LS-SVM. We retained 5 and 15 components respec-
tively for cervical and colon cancer data sets. For PCA, the
optimal number of components were selected by slightly
modifying the Equation 6, i.e., which performed only for
the components k as follows:
J(k) = argmax
k∈N0
1
N
k∑
n=1
N∑
j=1
∫ ∣∣∣z(−j)npca (x)∣∣∣ dx (8)
where znpca(x) the score corresponding to the varibale x on
PCA problem. (See Equation 1).
Figure 5 shows the plots of the optimal components
selection of PCA. Thus we retained 13 components and
15 components for cervical and colon cancer respectively
for PCA. Similarly, we obtained number of components of
PCA and the number of components with corresponding
bandwidth for KPCA for the remaining data sets.
The score variables (projection of samples onto the
direction of selected principal components) are used to
develop an LS-SVM classification model. The averaged
test AUC values over the 30 random repetitions were
reported.
The main goal of PCA is the reduction of dimension-
ality, that is, focusing on a few principal components
(PC) versus many variables. There are several criteria
have been proposed for determining howmany PC should
be investigated and how many should be ignored. One
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Figure 4 Slice plot for the Model selection for KPCA for the optimal bandwidth. (a) Cervical cancer (b) Colon cancer.
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Table 2 Comparison of classifiers:Mean AUC(std) of 30 iterations
Data set Kernel function Preprocessing + LS-SVM classifier PAM Lasso
for classification
Whole data PCA KPCA t-test (p < 0.05)
RBF 0.769(0.127) 0.793(0.081) 0.822(0.088) 0.835(0.078)
I lin 0.822(0.068) 0.837(0.088) 0.864(0.078) 0.857(0.078) 0.787(0.097) 0.837(0.116)
poly 0.818(0.071) 0.732(0.072) 0.825(0.125) 0.845(0.017)
RBF 0.637(0.146) 0.749(0.093) 0.780(0.076) 0.779(0.082)
II lin 0.803(0.059) 0.772(0.094) 0.790(0.075) 0.751(0.071) 0.659(0.084) 0.766(0.074)
poly 0.701(086) 0.752(0.063) 0.753(0.072) 0.784(0.059)
RBF 0.832(0.143) 0.762(0.066) 0.879(0.058) 0.921(0.027)
III lin 0.915(0.043) 0.785(0.063) 0.878(0.066) 0.941(0.036) 0.707(0.067) 0.9359( 0.0374)
poly 0.775(0.080) 0.685(0.105) 0.8380(0.068) 0.858(0.042)
RBF 0.615(0.197) 0.853(0.112) 0.867(0.098) 0.808(0.225)
IV lin 0.953(0.070) 0.917(0.083) 0.929(0.077) 0.987(0.028) 0.759(0.152) 0.707(0.194)
poly 0.762(0.118) 0.811(0.140) 0.840(0.131) 0.779(0.123)
RBF 0.807(0.238) 0.790(0.140) 0.976(0.035) 0.998(0.005)
V lin 0.997(0.005) 0.528(0.134) 0.982(0.022) 0.998(0.006) 0.923(0.062) 0.934(0.084)
poly 0.942(0.051) 0.804(0.121) 0.975(0.028) 0.965(0.049)
RBF 0.998(0.001) 0.982(0.002) 0.984(0.012) 0.998(0.004)
VI lin 0.990(0.005) 0.973(0.002) 0.978(0.013) 0.993(0.013) 0.960(0.016) 0.951(0.045)
poly 0.998(0.006) 0.985(0.016) 0.973(0.018) 0.995(0.011)
RBF 0.946(0.098) 0.941(0.057) 0.932(0.071) 0.967(0.048)
VII lin 0.983(0.025) 0.947(0.047) 0.954(0.051) 0.987(0.022) 0.931(0.058) 0.952(0.030)
poly 0.785(0.143) 0.903(0.078) 0.915(0.080) 0.920(0.025)
RBF 0.823(0.159) 0.923(0.096) 0.858(0.113) 0.950(0.150)
VIII lin 0.840(0.164) 0.969(0.044) 0.800(0.019) 0.999(0.005) 0.982(0.050) 0.890(0.081)
poly 0.781(0.186) 0.870(0.117) 0.785(0.121) 0.998(0.007)
RBF 0.638(0.210) 0.823(0.159) 0.852(0.180) 0.815(0.200)
IX lin 0.931(0.126) 0.840(0.164) 0.846(0.143) 0.930(0.139) 0.703(0.175) 0.705(0.174)
poly 0.841(0.176) 0.781(0.186) 0.798(0.193) 0.768(0.193)
p-value: False Discovery Rate (FDR) corrected.
common criteria is to include all those PCs up to a prede-
termined total percent variance explained, such as, 95%.
Figure 6 depicts the prediction performances on colon
cancer data, with PCA+LS-SVM(RBF), at different frac-
tions of explained total variance. It shows the results
vary with the selected components. Here the number of
retained components, depends on the chosen fraction of
explained total variance. The proposed approach offers a
data-driven selection criterion for PCA problem, instead
of a traditional trial and error PC selection.
Comparison between the proposed criterion and an existing
optimization algorithm for RBF-KPCA
We selected two experiments from Pochet et al. [17] (last
two data sets in Table 1), being high-grade glioma and
breast cancer II data sets. We repeated the same experi-
ments as reported in Pochet et al. [17] and compared with
the proposed strategy. The results are shown in Table 5.
The three dimensional surface plot of LOOCV perfor-
mance of the method proposed by [17] for the high-grade
glioma data set is shown in Figure 7, with the optimal
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Table 3 Summary of averaged execution time of classifiers over 30 iterations in seconds
Data set Whole data PCA KPCA t-test (p < 0.05) PAM Lasso
1: Colon 17 10 18 13 8 72
2: Breast 56 38 54 42 12 258
3: Pancreatic 17 12 26 19 20 453
4: Cervical 43 28 29 33 43 106
5: Leukemia 225 185 184 195 28 680
6: Ovarian 51 25 39 44 19 865
7: Head & neck squamous
cell carcinoma 59 39 45 47 30 238
8: Duchenne muscular dystrophy 146 115 113 110 80 20100
9: HIV encephalitis 45 27 27 28 88 118
Table 4 Statistical significance test which compares KPCAwith other classifiers: whole data, PCA, t-test, PAM and Lasso
Kernel function Data set I II III IV V VI VII VIII IX
Whole data 1.0000 1.0000 0.9250 0.0015 0.5750 0.0400 0.0628 0.0200 0.0150
PCA 0.0050 0.0021 0.0003 0.0015 2.83E-08 5.00E-07 0.0250 0.0005 0.0140
RBF t-test 1.0000 1.0000 1.0000 1.0000 6.50E-04 4.35E-04 0.0110 0.0005 1.0000
PAM 1.0000 6.10E-05 0.0002 0.0800 0.1450 0.0462 1.0000 0.0002 0.0015
Lasso 0.0278 1.000 0.0001 0.0498 1.0000 0.0015 1.0000 0.00003 0.0200
Whole data 1.0000 0.3095 1.0000 1.0000 1.0000 1.0000 1.0000 0.0009 1.0000
PCA 7.00E-05 0.0011 1.30E-09 7.70E-09 1.28E-08 2.72E-05 6.15E-07 0.357 0.230
lin t-test 1.0000 0.2150 0.7200 1.0000 0.0559 0.0443 1.0000 0.5450 1.0000
PAM 0.0400 0.0003 0.0422 0.0015 0.0004 0.0001 0.0015 1.0000 0.0300
Lasso 0.4950 0.4950 0.0049 2.12E-06 0.0005 0.0493 0.0025 1.0000 2.12E-06
Whole data 1.0000 0.0100 1.0000 4.16E-11 0.00450 5.90E-08 7.70E-08 1.0000 1.0000
PCA 0.0130 0.0003 4.35E-07 4.50E-05 7.70E-08 0.0040 3.28E-08 2.72E-05 5.00E-11
poly t-test 1.0000 1.0000 0.0250 1.0000 0.0443 0.2100 1.0000 0.0005 1.0000
PAM 0.1200 0.0005 0.0100 0.0400 0.0300 1.0000 0.0015 0.0200 0.0650
Lasso 0.0100 1.0000 4.61E-05 1.76E-08 0.5000 1.0000 0.0006 0.0010 0.4350
P-values of two-sided signed test are given.
p-value: False Discovery Rate (FDR) corrected.
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Figure 5 Plot for the selection of optimal number of components for PCA. (a) Cervical cancer (b) Colon cancer.
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Figure 6 The prediction performances on colon cancer data, with PCA+LS-SVM(RBF). Number of selected components depends on the
chosen fraction of explained total variance.
h = 114.018 and k = 12. The optimum parameters are
h = 94.868 and k = 10 obtained by the proposed strategy
(see Eq. 6) for the same data set.
When looking at test AUC in Table 5, both case studies
applying the proposed strategy, perform better than the
method proposed by Pochet et al.[17] with less variability.
In addition, the tuning method Pochet et al. [17] appears
to be quite time consuming, whereas the proposed model
enjoys a distinctive advantage with its low time complexity
to carry out the same process.
Comparison between the proposed criterion and other
classifiers
In Table 4, we have highlighted the comparisons in which
the proposedmethod was significantly better. When look-
ing specifically on the performance of each of the dis-
cussed methods, we note that LS-SVM performance was
slightly low on PCA. On data sets IV, VI, VII proposed
approach performs better than, LS-SVM with RBF kernel
and LS-SVMwith linear kernel. The proposed approach is
outperformed, by the t-test + LS-SVM on data sets V and
VI and, by both PAM and Lasso on most of the data sets.
Table 5 Comparison of performance of proposed criterion
with themethod proposed by Pochet et al. [17]: Averaged
test AUC(std) over 30 iterations and execution time in
minutes
Data set Proposed
strategy
Pochet
et al. [17]
Test AUC Time Test AUC Time
High-grade
glioma data
0.746 (0.071) 2 0.704
(0.104)
38
Breast cancer II 0.6747
(0.1057)
4 0.603
(0.157)
459
Discussions
The obtained test AUC of different classifiers on nine
data sets, do not direct to a common conclusion that
one method outperforms the other. Instead, it shows
that each of these methods have its own advantage in
classification tasks.When considering classification prob-
lems without dimensionality reduction, the regularized
LS-SVM classifier shows a good performance on 50 per-
centage of data sets. Up till now,mostmicroarray data sets
are smaller in the sense of number of features and sam-
ples, but it is expected that these data sets might become
larger or perhaps represent more complex classification
problems in the future. In this situation, dimension-
ality reduction processes (feature selection and feature
transformation) are the essential steps for building sta-
ble, robust and interpretable classifiers on these kind of
data.
The selected features of feature selection method such
as t-test, PAM and Lassowidely vary for each random iter-
ation. Moreover, the classification performance of these
methods on each iteration depends on the number of
features selected. Table 6 shows the range, i.e. minimum
and maximum number of features selected on 30 itera-
tions. However PAM is a user friendly toolbox for gene
selection and classification tasks, its performance depends
heavily on the selected features. In addition, it is interest-
ing that the Lasso selected only very small subsets of the
actual data sets. But, in the Lasso, the amount of shrinkage
varies, depending on the value of the tuning parame-
ter, which is often determined by cross validation [37].
The number of genes selected as the outcome-predictive
genes, generally decrease as the value of the tuning param-
eter increases. The optimal value of the tuning parameter,
that maximizes the prediction accuracy is determined;
however, the set of genes identified using the optimal
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Figure 7 LOOCV performance of optimization algorithm [17] on high-grade glioma data set.
value contains the non-outcome-predictive genes (ie, false
positive genes) in many cases [9].
The test AUC on all nine case studies shows that KPCA
performs better than classical PCA. But the parameters of
KPCA need to be optimized. Here we have used LOOCV
approach for parameters selection (bandwidth and num-
ber of components) of KPCA. In the optimization algo-
rithm proposed by Pochet et al. [17], the combination of
KPCA with RBF kernel followed by FDA tends to result
Table 6 Summary of the range (minimum tomaximum) of
features selectedover 30 iterations
Data set t-test (p < 0.05) PAM Lasso
1: Colon 197-323 15-373 8-36
2: Breast 993-1124 13-4718 7-87
3: Pancreatic 2713-4855 3-1514 12-112
4: Cervical 5858-6756 2-10692 5-67
5: Leukemia 1089-2654 137-11453 2-69
6: Ovarian 7341-7841 34-278 62-132
7: Head and neck
squamous
cell carcinoma 307-831 1-12625 3-35
8: Duchenne
muscular dystrophy
973-2031 129-22283 8-24
9: HIV encephalitis 941-1422 1-12625 1-20
p-value: False Discovery Rate (FDR) corrected.
in overfitting. The proposed parameter selection criterion
of KPCA with RBF kernel, often results in test set per-
formances (see Table 4) that is better than using KPCA
with a linear kernel, which reported in Pochet et al. It
means that LOOCV in the proposed parameter selection
criterion does not encounter an overfitting for KPCA with
RBF kernel function. In addition, the optimization algo-
rithmproposedby Pochet et al. is completely coupled with
the subsequent classifier and thus it appears to be very
time-consuming.
In combination with classification methods, microarray
data analysis can be useful to guide clinical management
in cancer studies. In this study, several mathematical and
statistical techniques were evaluated and compared in
order to optimize the performance of clinical predictions
based on microarray data. Considering the possibility of
increasing size and complexity of microarray data sets
in future, dimensionality reduction and nonlinear tech-
niques have its own significance. In many cases, in a
specific application context the best feature set is still
important (e.g. drug discovery). While considering the
stability and performance (both accuracy and execution
time) of classifiers, the proposedmethodology has its own
importance to predict classes, of future samples of known
disease cases.
Finally this work could be extended further to uncover
key features from biological data sets. In several studies,
KPCA have used to obtain biologically relevant features
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such as genes [38,39] or detect the association between
multiple SNPs and disease [40]. In all these cases, one
needs to address the parameter optimization of KPCA.
The available bandwidth selection techniques of KPCA
are time-consuming with high computational burden.
This could be resolved with the proposed data-driven
bandwidth selection criterion for KPCA.
Conclusion
The objective in class prediction with microarray data
is an accurate classification of cancerous samples, which
allows directed and more successful therapies. In this
paper, we proposed a new data-driven bandwidth selec-
tion criterion for KPCA (which is a well defined prepro-
cessing technique). In particular, we optimize the band-
width and the number of components by maximizing the
projected variance of KPCA. In addition, we compared
several data preprocessing techniques prior to classifica-
tion. In all the case studies, most of these preprocessing
steps performed well on classification with approximately
similar performance. We observed that in feature selec-
tion methods selected features widely vary on each iter-
ation. Hence it is difficult, even impossible to design
a stable class predictor for future samples with these
methods. Experiments on nine data sets show that the
proposed strategy provides a stable preprocessing algo-
rithm for classification of high dimensional data with good
performance on test data.
The advantages of the proposed KPCA+LS-SVM clas-
sifier were presented in four aspects. First, we propose a
data-driven bandwidth selection criterion for KPCA by
tuning the optimum bandwidth and the number of prin-
cipal components. Second, we illustrate that the perfor-
mance of the proposed strategy is significantly better than
an existing optimization algorithm for KPCA. Third, its
classification performance is not sensitive to any number
of selected genes, so the proposed method is more sta-
ble than others proposed in literature. Fourth, it reduces
the dimensionality of the data while keeping as much
information as possible of the original data. This leads to
computationally less expensive and more stable results for
massive microarray classification.
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